Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Dexmedetomidine film for agitation associated with bipolar disorder	Dexmedetomidine	Bipolar disorder	Mental and Behavioural Health	2022	View \| Download
Deucravacitinib for treating active psoriatic arthritis	Deucravacitinib (BMS-986165)	Psoriatic arthritis	Dermatology , Rheumatology	2023	View \| Download
Dersimelagon for previously untreated erythropoietic protoporphyria and X-linked protoporphyria	Dersimelagon	Erythropoietic protoporphyria , X-linked protoporphyria	Dermatology , Haematology	2022	View \| Download
DermaSys for erectile dysfunction	Glyceryl Trinitrate (MED2002; MED2005; Eroxon; DermaSys)	Erectile dysfunction	Men's Health	2020	View \| Download
Depemokimab for treating chronic rhinosinusitis withnasal polyps	Depemokimab	Nasal polyps , Rhinosinusitis	Ear Nose and Throat (ENT)	2024	View \| Download
Depemokimab as adjunctive therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and older	Depemokimab	Asthma	Respiratory System	2024	View \| Download
Depatuxizumab mafodotin for newly diagnosed EGFR‐amplified glioblastoma – first line	Depatuxizumab mafodotin (ABT-414) , Temozolomide (Temodar; Temodal; SCH 52365)	Glioma	Neurological Cancer	2018	View \| Download
Denosumab for the prevention of skeletal related events in patients with multiple myeloma – first line	Denosumab (AMG 162; Prolia; Xgeva)	Prevention of skeletal related events in multiple myeloma	Haematological Cancer and Lymphomas , Musculoskeletal System	2017	View \| Download
Denosumab biosimilar for treating postmenopausal osteoporosis	Denosumab biosimilar	Postmenopausal osteoporosis	Musculoskeletal System	2022	View \| Download
Delgocitinib for treating moderate to severe chronic hand eczema after 1 previous therapy	Delgocitinib	Chronic hand eczema	Dermatology	2023	View \| Download